SHIFT Newsroom · GLOBAL
Trial Evaluates Switching from Semaglutide to Zovaglutide in Adults with Obesity
A study is assessing the safety and tolerability of switching from Semaglutide to Zovaglutide in adults with obesity, as listed on ClinicalTrials.gov.
A study listed on ClinicalTrials.gov is assessing the safety and tolerability of switching from Semaglutide to Zovaglutide in adults with obesity. The trial, known as HORIZON-SWITCH-SZ, may provide insights into the potential use of Zovaglutide as an alternative to Semaglutide for adults with obesity.
What this means in the UK
This trial may provide insights into the potential use of Zovaglutide as an alternative to Semaglutide for adults with obesity in the UK, but its relevance and implications for UK patients and healthcare systems are currently unknown.
Known facts
- A study is evaluating the safety and tolerability of switching from Semaglutide to Zovaglutide in adults with obesity.